Abstract

Background

Right hemicolectomy is the standard treatment for right-sided colon cancer. There is variation in the technical aspects of performing right hemicolectomy as well as in short-term outcomes. It is therefore necessary to explore best clinical practice following right hemicolectomy in expert centres.

Methods

This snapshot study of right hemicolectomy for colon cancer in China was a prospective, multicentre cohort study in which 52 tertiary hospitals participated. Eligible patients with stage I–III right-sided colon cancer who underwent elective right hemicolectomy were consecutively enrolled in all centres over 10 months. The primary endpoint was the incidence of postoperative 30-day anastomotic leak.

Results

Of the 1854 patients, 89.9 per cent underwent laparoscopic surgery and 52.3 per cent underwent D3 lymph node dissection. The overall 30-day morbidity and mortality were 11.7 and 0.2 per cent, respectively. The 30-day anastomotic leak rate was 1.4 per cent. In multivariate analysis, ASA grade > II (P < 0.001), intraoperative blood loss > 50 ml (P = 0.044) and D3 lymph node dissection (P = 0.008) were identified as independent risk factors for postoperative morbidity. Extracorporeal side-to-side anastomosis (P = 0.031), intraoperative blood loss > 50 ml (P = 0.004) and neoadjuvant chemotherapy (P = 0.004) were identified as independent risk factors for anastomotic leak.

Conclusion

In high-volume expert centres in China, laparoscopic resection with D3 lymph node dissection was performed in most patients with right-sided colon cancer, and overall postoperative morbidity and mortality was low. Further studies are needed to explore the optimal technique for right hemicolectomy in order to improve outcomes further.

Introduction

Colorectal cancer is the third commonest malignancy in China1, with right hemicolectomy (RHC) being the standard treatment for right-sided colon cancer. The surgical steps for right hemicolectomy are highly diverse and constantly evolving, with new concepts such as complete mesocolic excision (CME)2–6 and intracorporeal ileocolic anastomosis (IIA)7–9. High-quality studies are needed to further validate these techniques and understand their impact on short-term outcomes.

Anastomotic leak is a major complication after RHC and a risk factor for mortality and postoperative recurrence10–14. Analysis of predictors for anastomotic leak showed an obvious correlation with patient condition (malnutrition), surgical experience and surgical technique (hand-sewn anastomosis, open approach)10,11. However, previous studies have considered multiple factors, and few studies have examined the effect of the technical aspects of surgery, particularly the latest techniques (for example, CME, intracorporeal anastomosis), on complications and anastomotic leak rates.

By prospectively collecting data from high-volume expert centres in China, and in particular documenting the surgical approach, this study describes the implementation of technological advances in RHC and their impact on short-term outcomes (morbidity, anastomotic leak) and provides the direction and foundation for further high-quality studies. This study also serves as the first step of the COLOR IV trial (NCT05493033), an international multicentre study comparing intracorporeal and extracorporeal anastomosis after laparoscopic RHC.

Methods

Study design

This study was a multicentre, prospective, observational study to explore the clinical practice and short-term outcomes of right hemicolectomy in high-volume expert centres in China, as well as to establish the risk factors for postoperative morbidity and anastomotic leak. The study was registered at ClinicalTrials.gov (NCT04628182) and was conducted in accordance with the published research protocol (Appendix 1). A total of 71 tertiary hospitals in China were invited, and 52 centres that perform more than 120 colon cancer operations per year were enrolled in this study (Fig. S1). All participating centres were required to enrol consecutive eligible cases for 10 months and complete the 30-day follow-up.

Patients

Patients with stage I–III right-sided colon cancer (caecum, ascending colon, and proximal two-thirds of the transverse colon) who underwent elective RHC were enrolled in this study. Patients with inflammatory bowel disease (Crohn’s disease or ulcerative colitis) requiring emergency surgery or a more extensive procedure (subtotal colectomy, pan proctocolectomy, or planned synchronous abdominal organ resections) were excluded.

Outcomes

The primary outcome was 30-day postoperative anastomotic leak rate. Anastomotic leak was defined as a defect of the intestinal wall at the anastomotic site leading to communication between intra- and extraluminal compartments15,16. The diagnosis of anastomotic leak was initially based on clinical signs (fever, abnormal drain output, leukocytosis, etc.) and confirmed radiologically, endoscopically, or intraoperatively. Patients with suspected anastomotic leak were required to have an abdominal CT scan. The severity of anastomotic leak was classified according to the Clavien–Dindo classification17 and the International Study Group of Rectal Cancer grading (ISREC) standards18.

The secondary outcomes were 30-day postoperative morbidity, mortality, reoperation rate, readmission rate, postoperative bowel function recovery, and length of hospital stay. The severity of complications was assessed according to the Clavien–Dindo classification17.

Data collection

All data were collected in an online database (https://color4.dpclouds.com:8098/login). To ensure data completion, approximately 90 per cent of the data fields were mandatory.

The data were recorded as follows: demographic, preoperative, surgical, pathological, and postoperative information. The detailed surgical data were provided by the surgeons. The superior mesenteric artery (SMA) was classified into four patterns. Pattern I was the independent origin of the ileocolic artery (ICA), right colic artery (RCA), and middle colic artery (MCA). Pattern IIa was a common trunk between the RCA and MCA, pattern IIb was a common trunk between the RCA and ICA, and pattern IIc was a common trunk for the ICA, RCA, and MCA. Pattern III was an absence of RCA. Pattern IV was the presence of accessory arteries19. The classification of Henle’s trunk was recorded according to the Miyazawa criteria (type 0, I, II, III) determined according to the number of colic veins that ran into the main trunk20. The extent of the resection was determined as limited (proximal to hepatic flexure), complete (hepatic flexure to the middle), and extended (middle to distal transverse colon).

Statistical analysis

Categorical variables are presented as numbers and percentages. Continuous variables are presented as the median and 25th–75th percentiles. Variables selected for risk factor analysis were identified by the Least Absolute Shrinkage and Selection Operator (LASSO) technique21. By choosing the optimal penalty parameter (λ) correlated with the minimum 10-fold cross-validation, factors associated with the outcomes of interest were further analysed using multivariate logistic regression. The factors selected by LASSO underwent univariate analysis, and factors with P < 0.1 were subsequently subjected to multivariate analysis. P < 0.05 was considered statistically significant. R software (version 4.2.1) was used to perform the LASSO and logistic regression.

Results

Demographic information

A total of 2289 patients from 52 tertiary hospitals were enrolled from September 2021 to June 2022, of which 1915 (83.7 per cent) completed 30-day follow-up and submitted all data. After excluding 37 patients for metastasis, no malignancy, carcinoma in situ, and formation of ileostomy, 1854 patients were available for analysis (Fig. 1, Fig. S1). The median (i.q.r. age of patients was 64 (55–72) years, and median (i.q.r.) BMI was 23.2 (21.1–25.4) kg/m2. Detailed patient and tumour characteristics are reported in Table 1.

Flowchart of the study design
Fig. 1

Flowchart of the study design

Table 1

Characteristics of patients and tumours

Median age (years)64 (55–72)
Median BMI (kg/m2)23.2 (21.1–25.4)
Sex ratio (M:F)978:876
ECOG score
 0–11696 (91.5)
 2–4158 (8.5)
ASA fitness grade
 I–II1637 (88.3)
 III–IV217 (11.7)
NRS2002 score
 <3626 (33.8)
 ≥3555 (29.9)
 NA673 (36.3)
History of abdominal surgery458 (24.7)
Chronic obstructive pulmonary disease55 (3.0)
Heart disease
 Coronary artery disease110 (5.9)
 Heart arrhythmias21 (1.1)
 Heart failure23 (1.2)
 Heart valve disease5 (0.3)
Anaemia
 Mild402 (21.7)
 Moderate616 (33.2)
 Severe260 (14.0)
Anaemia treatment
 Iron infusion106 (5.7)
 Blood transfusion159 (8.6)
Albumin (g/l)
 >351383 (74.6)
 30–35369 (19.9)
 25–3090 (4.9)
 <2512 (0.6)
Diabetes mellitus261 (14.1)
 Diet controlled19 (7.3)
 Tablet controlled194 (74.3)
 Insulin controlled48 (18.4)
Preoperative intestinal obstruction356 (19.2)
Preoperative haematochezia729 (39.3)
Elevated creatinine (>133 µmol/l)30 (1.6)
Tobacco use229 (12.4)
Statin use82 (4.4)
Anticoagulant use98 (5.3)
Elevated CEA (>5 ng/ml)644 (34.7)
Neoadjuvant chemotherapy70 (3.8)
Pathological T category
 193 (5.0)
 2187 (10.0)
 3948 (51.1)
 4a585 (31.6)
 Not recorded41 (2.2)
Pathological N category
 0977 (52.7)
 1630 (34.0)
 2192 (10.4)
 Not recorded55 (3.0)
Median age (years)64 (55–72)
Median BMI (kg/m2)23.2 (21.1–25.4)
Sex ratio (M:F)978:876
ECOG score
 0–11696 (91.5)
 2–4158 (8.5)
ASA fitness grade
 I–II1637 (88.3)
 III–IV217 (11.7)
NRS2002 score
 <3626 (33.8)
 ≥3555 (29.9)
 NA673 (36.3)
History of abdominal surgery458 (24.7)
Chronic obstructive pulmonary disease55 (3.0)
Heart disease
 Coronary artery disease110 (5.9)
 Heart arrhythmias21 (1.1)
 Heart failure23 (1.2)
 Heart valve disease5 (0.3)
Anaemia
 Mild402 (21.7)
 Moderate616 (33.2)
 Severe260 (14.0)
Anaemia treatment
 Iron infusion106 (5.7)
 Blood transfusion159 (8.6)
Albumin (g/l)
 >351383 (74.6)
 30–35369 (19.9)
 25–3090 (4.9)
 <2512 (0.6)
Diabetes mellitus261 (14.1)
 Diet controlled19 (7.3)
 Tablet controlled194 (74.3)
 Insulin controlled48 (18.4)
Preoperative intestinal obstruction356 (19.2)
Preoperative haematochezia729 (39.3)
Elevated creatinine (>133 µmol/l)30 (1.6)
Tobacco use229 (12.4)
Statin use82 (4.4)
Anticoagulant use98 (5.3)
Elevated CEA (>5 ng/ml)644 (34.7)
Neoadjuvant chemotherapy70 (3.8)
Pathological T category
 193 (5.0)
 2187 (10.0)
 3948 (51.1)
 4a585 (31.6)
 Not recorded41 (2.2)
Pathological N category
 0977 (52.7)
 1630 (34.0)
 2192 (10.4)
 Not recorded55 (3.0)

Values are n (%) unless otherwise indicated. Anaemia was defined according to WHO criteria. TNM stage adopted the AJCC 8th edition.

Table 1

Characteristics of patients and tumours

Median age (years)64 (55–72)
Median BMI (kg/m2)23.2 (21.1–25.4)
Sex ratio (M:F)978:876
ECOG score
 0–11696 (91.5)
 2–4158 (8.5)
ASA fitness grade
 I–II1637 (88.3)
 III–IV217 (11.7)
NRS2002 score
 <3626 (33.8)
 ≥3555 (29.9)
 NA673 (36.3)
History of abdominal surgery458 (24.7)
Chronic obstructive pulmonary disease55 (3.0)
Heart disease
 Coronary artery disease110 (5.9)
 Heart arrhythmias21 (1.1)
 Heart failure23 (1.2)
 Heart valve disease5 (0.3)
Anaemia
 Mild402 (21.7)
 Moderate616 (33.2)
 Severe260 (14.0)
Anaemia treatment
 Iron infusion106 (5.7)
 Blood transfusion159 (8.6)
Albumin (g/l)
 >351383 (74.6)
 30–35369 (19.9)
 25–3090 (4.9)
 <2512 (0.6)
Diabetes mellitus261 (14.1)
 Diet controlled19 (7.3)
 Tablet controlled194 (74.3)
 Insulin controlled48 (18.4)
Preoperative intestinal obstruction356 (19.2)
Preoperative haematochezia729 (39.3)
Elevated creatinine (>133 µmol/l)30 (1.6)
Tobacco use229 (12.4)
Statin use82 (4.4)
Anticoagulant use98 (5.3)
Elevated CEA (>5 ng/ml)644 (34.7)
Neoadjuvant chemotherapy70 (3.8)
Pathological T category
 193 (5.0)
 2187 (10.0)
 3948 (51.1)
 4a585 (31.6)
 Not recorded41 (2.2)
Pathological N category
 0977 (52.7)
 1630 (34.0)
 2192 (10.4)
 Not recorded55 (3.0)
Median age (years)64 (55–72)
Median BMI (kg/m2)23.2 (21.1–25.4)
Sex ratio (M:F)978:876
ECOG score
 0–11696 (91.5)
 2–4158 (8.5)
ASA fitness grade
 I–II1637 (88.3)
 III–IV217 (11.7)
NRS2002 score
 <3626 (33.8)
 ≥3555 (29.9)
 NA673 (36.3)
History of abdominal surgery458 (24.7)
Chronic obstructive pulmonary disease55 (3.0)
Heart disease
 Coronary artery disease110 (5.9)
 Heart arrhythmias21 (1.1)
 Heart failure23 (1.2)
 Heart valve disease5 (0.3)
Anaemia
 Mild402 (21.7)
 Moderate616 (33.2)
 Severe260 (14.0)
Anaemia treatment
 Iron infusion106 (5.7)
 Blood transfusion159 (8.6)
Albumin (g/l)
 >351383 (74.6)
 30–35369 (19.9)
 25–3090 (4.9)
 <2512 (0.6)
Diabetes mellitus261 (14.1)
 Diet controlled19 (7.3)
 Tablet controlled194 (74.3)
 Insulin controlled48 (18.4)
Preoperative intestinal obstruction356 (19.2)
Preoperative haematochezia729 (39.3)
Elevated creatinine (>133 µmol/l)30 (1.6)
Tobacco use229 (12.4)
Statin use82 (4.4)
Anticoagulant use98 (5.3)
Elevated CEA (>5 ng/ml)644 (34.7)
Neoadjuvant chemotherapy70 (3.8)
Pathological T category
 193 (5.0)
 2187 (10.0)
 3948 (51.1)
 4a585 (31.6)
 Not recorded41 (2.2)
Pathological N category
 0977 (52.7)
 1630 (34.0)
 2192 (10.4)
 Not recorded55 (3.0)

Values are n (%) unless otherwise indicated. Anaemia was defined according to WHO criteria. TNM stage adopted the AJCC 8th edition.

Surgical details

More than 95 per cent of RHCs were completed by the chief or associate chief surgeon. In addition, 89.9 per cent of patients underwent laparoscopic surgery with a 4 per cent conversion rate. D3 lymph node dissection was performed for 52.3 per cent patients, and D2 lymph node dissection for 47.0 per cent. The median (i.q.r.) duration of surgery was 180 (140–210) minutes. Intraoperative complications occurred in 4.9 per cent of patients, the most common of which were bleeding (3.1 per cent) and vascular injury (1.1 per cent) (Table S1). Technical details of the surgery performed are reported in Table 2. The superior mesenteric artery was identified in 90 per cent of patients, with type 1 being the most common (41.3 per cent). Similarly, Henle’s trunk was identified in 86.8 per cent, with almost half (48.7 per cent) being type I (Table S2).

Table 2

Technical details of the surgery

Performing surgeon
 Chief surgeon1209 (65.2)
 Associate chief surgeon594 (32.0)
 Attending surgeon51 (2.8)
Type of right hemicolectomy
 Limited (C1–3)76 (4.1)
 Complete (C4–5)1482 (79.9)
 Extended (C6–7)296 (16.0)
Surgical approach
 Open188 (10.1)
 Laparoscopic1666 (89.9)
 Convert to hand-assisted laparoscopic surgery*11 (0.7)
 Convert to open surgery*55 (3.3)
Resection approach
 Medial809 (43.3)
 Lateral336 (18.2)
 Mixed709 (38.4)
Lymph-node dissection
 D114 (0.8)
 D2871 (47.0)
 D3969 (52.3)
Middle colic artery ligation
 Right branch1156 (62.4)
 Root512 (27.6)
 Not recorded186 (10.0)
Right gastro-epiploic vein ligation522 (28.2)
Energy device used
 Ultrasonic dissector1361 (73.4)
 Monopolar/bipolar diathermy76 (4.1)
 Both417 (22.5)
Abdominal incision
 Upper median1140 (61.5)
 Umbilical219 (11.8)
 Lower median159 (8.6)
 Transverse96 (5.2)
 Other240 (12.9)
Mesenteric defect closure783 (42.2)
Intraoperative blood loss (ml)
 0–501238 (66.8)
 50–200567 (30.6)
 >20049 (2.6)
Surgical duration (min)180 (140–210)
Performing surgeon
 Chief surgeon1209 (65.2)
 Associate chief surgeon594 (32.0)
 Attending surgeon51 (2.8)
Type of right hemicolectomy
 Limited (C1–3)76 (4.1)
 Complete (C4–5)1482 (79.9)
 Extended (C6–7)296 (16.0)
Surgical approach
 Open188 (10.1)
 Laparoscopic1666 (89.9)
 Convert to hand-assisted laparoscopic surgery*11 (0.7)
 Convert to open surgery*55 (3.3)
Resection approach
 Medial809 (43.3)
 Lateral336 (18.2)
 Mixed709 (38.4)
Lymph-node dissection
 D114 (0.8)
 D2871 (47.0)
 D3969 (52.3)
Middle colic artery ligation
 Right branch1156 (62.4)
 Root512 (27.6)
 Not recorded186 (10.0)
Right gastro-epiploic vein ligation522 (28.2)
Energy device used
 Ultrasonic dissector1361 (73.4)
 Monopolar/bipolar diathermy76 (4.1)
 Both417 (22.5)
Abdominal incision
 Upper median1140 (61.5)
 Umbilical219 (11.8)
 Lower median159 (8.6)
 Transverse96 (5.2)
 Other240 (12.9)
Mesenteric defect closure783 (42.2)
Intraoperative blood loss (ml)
 0–501238 (66.8)
 50–200567 (30.6)
 >20049 (2.6)
Surgical duration (min)180 (140–210)

Values are n (%) unless otherwise indicated. *Conversion rate was calculated by dividing the number of converted surgeries by the number of laparoscopic surgeries. Data presented as median (range).

Table 2

Technical details of the surgery

Performing surgeon
 Chief surgeon1209 (65.2)
 Associate chief surgeon594 (32.0)
 Attending surgeon51 (2.8)
Type of right hemicolectomy
 Limited (C1–3)76 (4.1)
 Complete (C4–5)1482 (79.9)
 Extended (C6–7)296 (16.0)
Surgical approach
 Open188 (10.1)
 Laparoscopic1666 (89.9)
 Convert to hand-assisted laparoscopic surgery*11 (0.7)
 Convert to open surgery*55 (3.3)
Resection approach
 Medial809 (43.3)
 Lateral336 (18.2)
 Mixed709 (38.4)
Lymph-node dissection
 D114 (0.8)
 D2871 (47.0)
 D3969 (52.3)
Middle colic artery ligation
 Right branch1156 (62.4)
 Root512 (27.6)
 Not recorded186 (10.0)
Right gastro-epiploic vein ligation522 (28.2)
Energy device used
 Ultrasonic dissector1361 (73.4)
 Monopolar/bipolar diathermy76 (4.1)
 Both417 (22.5)
Abdominal incision
 Upper median1140 (61.5)
 Umbilical219 (11.8)
 Lower median159 (8.6)
 Transverse96 (5.2)
 Other240 (12.9)
Mesenteric defect closure783 (42.2)
Intraoperative blood loss (ml)
 0–501238 (66.8)
 50–200567 (30.6)
 >20049 (2.6)
Surgical duration (min)180 (140–210)
Performing surgeon
 Chief surgeon1209 (65.2)
 Associate chief surgeon594 (32.0)
 Attending surgeon51 (2.8)
Type of right hemicolectomy
 Limited (C1–3)76 (4.1)
 Complete (C4–5)1482 (79.9)
 Extended (C6–7)296 (16.0)
Surgical approach
 Open188 (10.1)
 Laparoscopic1666 (89.9)
 Convert to hand-assisted laparoscopic surgery*11 (0.7)
 Convert to open surgery*55 (3.3)
Resection approach
 Medial809 (43.3)
 Lateral336 (18.2)
 Mixed709 (38.4)
Lymph-node dissection
 D114 (0.8)
 D2871 (47.0)
 D3969 (52.3)
Middle colic artery ligation
 Right branch1156 (62.4)
 Root512 (27.6)
 Not recorded186 (10.0)
Right gastro-epiploic vein ligation522 (28.2)
Energy device used
 Ultrasonic dissector1361 (73.4)
 Monopolar/bipolar diathermy76 (4.1)
 Both417 (22.5)
Abdominal incision
 Upper median1140 (61.5)
 Umbilical219 (11.8)
 Lower median159 (8.6)
 Transverse96 (5.2)
 Other240 (12.9)
Mesenteric defect closure783 (42.2)
Intraoperative blood loss (ml)
 0–501238 (66.8)
 50–200567 (30.6)
 >20049 (2.6)
Surgical duration (min)180 (140–210)

Values are n (%) unless otherwise indicated. *Conversion rate was calculated by dividing the number of converted surgeries by the number of laparoscopic surgeries. Data presented as median (range).

Anastomotic technique

Overall, 97.8 per cent of patients underwent stapled anastomosis, and 84.3 per cent underwent extracorporeal anastomosis. Side-to-side and end-to-side anastomosis accounted for 57.2 and 41.2 per cent, respectively. All intracorporeal anastomoses were side-to-side, with 87.3 per cent being isoperistaltic compared to 54.8 per cent of those performed extracorporeally. Further details of anastomotic technique are reported in Table 3.

Table 3

Details of anastomotic technique

Anastomotic approach
 Extracorporeal1562 (84.3)
 Intracorporeal292 (15.7)
Anastomotic technique
 Hand sewn41 (2.2)
 Stapled1813 (97.8)
Anastomotic type
 Side-to-side (intracorporeal)292 (15.7)
 Side-to-side (extracorporeal)769 (41.5)
 End-to-side764 (41.2)
 End-to-end29 (1.6)
Anastomotic type in side-to-side anastomosis*
 Isoperistaltic677 (63.8)
 Antiperistaltic384 (36.2)
Reinforcement
 Seromuscular layer suture801 (43.2)
 Full-thickness suture710 (38.3)
 No reinforcement168 (9.1)
 Not recorded175 (9.4)
Fluoresence (indocyanine green) use49 (2.6)
Anastomotic approach
 Extracorporeal1562 (84.3)
 Intracorporeal292 (15.7)
Anastomotic technique
 Hand sewn41 (2.2)
 Stapled1813 (97.8)
Anastomotic type
 Side-to-side (intracorporeal)292 (15.7)
 Side-to-side (extracorporeal)769 (41.5)
 End-to-side764 (41.2)
 End-to-end29 (1.6)
Anastomotic type in side-to-side anastomosis*
 Isoperistaltic677 (63.8)
 Antiperistaltic384 (36.2)
Reinforcement
 Seromuscular layer suture801 (43.2)
 Full-thickness suture710 (38.3)
 No reinforcement168 (9.1)
 Not recorded175 (9.4)
Fluoresence (indocyanine green) use49 (2.6)

Values are n (%) unless otherwise indicated. *Anastomotic type in side-to-side anastomosis was calculated by dividing the number of anastomosis in category of interest by the total number of side-to-side anastomoses.

Table 3

Details of anastomotic technique

Anastomotic approach
 Extracorporeal1562 (84.3)
 Intracorporeal292 (15.7)
Anastomotic technique
 Hand sewn41 (2.2)
 Stapled1813 (97.8)
Anastomotic type
 Side-to-side (intracorporeal)292 (15.7)
 Side-to-side (extracorporeal)769 (41.5)
 End-to-side764 (41.2)
 End-to-end29 (1.6)
Anastomotic type in side-to-side anastomosis*
 Isoperistaltic677 (63.8)
 Antiperistaltic384 (36.2)
Reinforcement
 Seromuscular layer suture801 (43.2)
 Full-thickness suture710 (38.3)
 No reinforcement168 (9.1)
 Not recorded175 (9.4)
Fluoresence (indocyanine green) use49 (2.6)
Anastomotic approach
 Extracorporeal1562 (84.3)
 Intracorporeal292 (15.7)
Anastomotic technique
 Hand sewn41 (2.2)
 Stapled1813 (97.8)
Anastomotic type
 Side-to-side (intracorporeal)292 (15.7)
 Side-to-side (extracorporeal)769 (41.5)
 End-to-side764 (41.2)
 End-to-end29 (1.6)
Anastomotic type in side-to-side anastomosis*
 Isoperistaltic677 (63.8)
 Antiperistaltic384 (36.2)
Reinforcement
 Seromuscular layer suture801 (43.2)
 Full-thickness suture710 (38.3)
 No reinforcement168 (9.1)
 Not recorded175 (9.4)
Fluoresence (indocyanine green) use49 (2.6)

Values are n (%) unless otherwise indicated. *Anastomotic type in side-to-side anastomosis was calculated by dividing the number of anastomosis in category of interest by the total number of side-to-side anastomoses.

Postoperative outcomes

Overall 30-day morbidity and mortality were 11.7 and 0.2 per cent, respectively. The overall median (i.q.r.) length of hospital stay was 13 (10–16) days, and the postoperative hospital stay was 8 (6–10) days. The median (i.q.r.) first passage of flatus and stool were 2 (2–3) days and 4 (3–5) days, respectively. Detailed postoperative information is reported in Table 4.

Table 4

Postoperative outcomes

Reoperation16 (0.9)
Readmission23 (1.2)
Mortality3 (0.2)
Morbidity216 (11.7)
Postoperative complications
 Anastomotic leak26 (1.4)
 Abdominal abscess10 (0.5)
 Wound infection41 (2.2)
 Chyle leak34 (3.4)
 Intra-abdominal bleeding12 (0.6)
 Intestinal bleeding9 (0.5)
 Ileus47 (2.5)
 Other78 (4.2)
Clavien–Dindo classification
 I89 (4.8)
 II124 (6.7)
 III36 (1.9)
 IV5 (0.3)
 V3 (0.2)
Time to first flatus*2 (2–3)
Time to first stool*4 (3–5)
Time to first diet*3 (2–4)
Length of hospital stay*13 (10–16)
Length of postoperative hospital stay*8 (6–10)
Reoperation16 (0.9)
Readmission23 (1.2)
Mortality3 (0.2)
Morbidity216 (11.7)
Postoperative complications
 Anastomotic leak26 (1.4)
 Abdominal abscess10 (0.5)
 Wound infection41 (2.2)
 Chyle leak34 (3.4)
 Intra-abdominal bleeding12 (0.6)
 Intestinal bleeding9 (0.5)
 Ileus47 (2.5)
 Other78 (4.2)
Clavien–Dindo classification
 I89 (4.8)
 II124 (6.7)
 III36 (1.9)
 IV5 (0.3)
 V3 (0.2)
Time to first flatus*2 (2–3)
Time to first stool*4 (3–5)
Time to first diet*3 (2–4)
Length of hospital stay*13 (10–16)
Length of postoperative hospital stay*8 (6–10)

Values are n (%) unless otherwise indicated. *Data are presented as median (range) number of days.

Table 4

Postoperative outcomes

Reoperation16 (0.9)
Readmission23 (1.2)
Mortality3 (0.2)
Morbidity216 (11.7)
Postoperative complications
 Anastomotic leak26 (1.4)
 Abdominal abscess10 (0.5)
 Wound infection41 (2.2)
 Chyle leak34 (3.4)
 Intra-abdominal bleeding12 (0.6)
 Intestinal bleeding9 (0.5)
 Ileus47 (2.5)
 Other78 (4.2)
Clavien–Dindo classification
 I89 (4.8)
 II124 (6.7)
 III36 (1.9)
 IV5 (0.3)
 V3 (0.2)
Time to first flatus*2 (2–3)
Time to first stool*4 (3–5)
Time to first diet*3 (2–4)
Length of hospital stay*13 (10–16)
Length of postoperative hospital stay*8 (6–10)
Reoperation16 (0.9)
Readmission23 (1.2)
Mortality3 (0.2)
Morbidity216 (11.7)
Postoperative complications
 Anastomotic leak26 (1.4)
 Abdominal abscess10 (0.5)
 Wound infection41 (2.2)
 Chyle leak34 (3.4)
 Intra-abdominal bleeding12 (0.6)
 Intestinal bleeding9 (0.5)
 Ileus47 (2.5)
 Other78 (4.2)
Clavien–Dindo classification
 I89 (4.8)
 II124 (6.7)
 III36 (1.9)
 IV5 (0.3)
 V3 (0.2)
Time to first flatus*2 (2–3)
Time to first stool*4 (3–5)
Time to first diet*3 (2–4)
Length of hospital stay*13 (10–16)
Length of postoperative hospital stay*8 (6–10)

Values are n (%) unless otherwise indicated. *Data are presented as median (range) number of days.

Through LASSO analysis, eight factors were selected as potential predictors of postoperative morbidity. At univariate and multivariate analysis, ASA grade > II (P < 0.001), D3 lymph node dissection (P = 0.008) and intraoperative blood loss > 50 ml (P = 0.044) were identified as independent risk factors for postoperative morbidity (Table 5, Fig. S2).

Table 5

Predictive factors for postoperative morbidity after right hemicolectomy for colon cancer

All patients (n = 1854)Patients with morbidity (n = 216)Patients without morbidity (n = 1638)P (univariate analysis)OR95% c.i.P (multivariate analysis)
ASA fitness grade<0.001<0.001
 I–II1637170 (10.4)1467 (89.6)1
 III–IV21746 (21.2)171 (78.8)2.1941.470–3.274
Lymph-node dissection0.008
 D287179 (9.1)792 (90.9)1
 D3969136 (14.0)833 (86.0)0.0011.6291.196–2.2180.002
 D1141 (7.1)14 (92.9)0.470.9070.115–7.1550.927
Intraoperative blood loss (ml)0.1090.044
 0–501238131 (10.6)1107 (89.4)1
 50–20056777 (13.6)490 (86.4)0.0651.4401.051–1.9740.023
 >200498 (16.3)41 (83.6)0.2081.7670.790–3.9560.183
Anastomotic type0.0160.160
 End-to-side76469 (9.0)695 (91.0)1
 Side-to-side (extracorporeal)769110 (14.3)659 (87.1)0.0011.451.1.045–2.0140.026
 Side-to-side (intracorporeal)29233 (11.3)259 (88.7)0.2651.2630.804–1.9840.310
 End-to-end294 (13.8)25 (86.2)0.3881.6480.541–5.0240.380
Mesenteric defect closure0.0530.102
 Yes78378 (10.0)705 (90.0)1
 No1071138 (12.9)933 (87.1)1.2870.951–1.742
ECOG score0.0270.776
 0–11696189 (11.1)1507 (88.9)1
 2–415827 (17.1)131 (82.9)1.0740.659–1.749
Albumin (g/l)0.0630.360
 >351383148 (10.7)1235 (89.3)1
 30–3536949 (13.3)320 (86.7)0.1651.1870.833–1.6900.343
 25–309016 (17.8)74 (82.2)0.0411.5010.837–2.6930.173
 <25123 (25.0)9 (75.0)0.1281.9760.512–7.6340.323
Surgical duration (min)183.1 (63.9)184.9 (61.0)182.8 (64.2)0.661
All patients (n = 1854)Patients with morbidity (n = 216)Patients without morbidity (n = 1638)P (univariate analysis)OR95% c.i.P (multivariate analysis)
ASA fitness grade<0.001<0.001
 I–II1637170 (10.4)1467 (89.6)1
 III–IV21746 (21.2)171 (78.8)2.1941.470–3.274
Lymph-node dissection0.008
 D287179 (9.1)792 (90.9)1
 D3969136 (14.0)833 (86.0)0.0011.6291.196–2.2180.002
 D1141 (7.1)14 (92.9)0.470.9070.115–7.1550.927
Intraoperative blood loss (ml)0.1090.044
 0–501238131 (10.6)1107 (89.4)1
 50–20056777 (13.6)490 (86.4)0.0651.4401.051–1.9740.023
 >200498 (16.3)41 (83.6)0.2081.7670.790–3.9560.183
Anastomotic type0.0160.160
 End-to-side76469 (9.0)695 (91.0)1
 Side-to-side (extracorporeal)769110 (14.3)659 (87.1)0.0011.451.1.045–2.0140.026
 Side-to-side (intracorporeal)29233 (11.3)259 (88.7)0.2651.2630.804–1.9840.310
 End-to-end294 (13.8)25 (86.2)0.3881.6480.541–5.0240.380
Mesenteric defect closure0.0530.102
 Yes78378 (10.0)705 (90.0)1
 No1071138 (12.9)933 (87.1)1.2870.951–1.742
ECOG score0.0270.776
 0–11696189 (11.1)1507 (88.9)1
 2–415827 (17.1)131 (82.9)1.0740.659–1.749
Albumin (g/l)0.0630.360
 >351383148 (10.7)1235 (89.3)1
 30–3536949 (13.3)320 (86.7)0.1651.1870.833–1.6900.343
 25–309016 (17.8)74 (82.2)0.0411.5010.837–2.6930.173
 <25123 (25.0)9 (75.0)0.1281.9760.512–7.6340.323
Surgical duration (min)183.1 (63.9)184.9 (61.0)182.8 (64.2)0.661
Table 5

Predictive factors for postoperative morbidity after right hemicolectomy for colon cancer

All patients (n = 1854)Patients with morbidity (n = 216)Patients without morbidity (n = 1638)P (univariate analysis)OR95% c.i.P (multivariate analysis)
ASA fitness grade<0.001<0.001
 I–II1637170 (10.4)1467 (89.6)1
 III–IV21746 (21.2)171 (78.8)2.1941.470–3.274
Lymph-node dissection0.008
 D287179 (9.1)792 (90.9)1
 D3969136 (14.0)833 (86.0)0.0011.6291.196–2.2180.002
 D1141 (7.1)14 (92.9)0.470.9070.115–7.1550.927
Intraoperative blood loss (ml)0.1090.044
 0–501238131 (10.6)1107 (89.4)1
 50–20056777 (13.6)490 (86.4)0.0651.4401.051–1.9740.023
 >200498 (16.3)41 (83.6)0.2081.7670.790–3.9560.183
Anastomotic type0.0160.160
 End-to-side76469 (9.0)695 (91.0)1
 Side-to-side (extracorporeal)769110 (14.3)659 (87.1)0.0011.451.1.045–2.0140.026
 Side-to-side (intracorporeal)29233 (11.3)259 (88.7)0.2651.2630.804–1.9840.310
 End-to-end294 (13.8)25 (86.2)0.3881.6480.541–5.0240.380
Mesenteric defect closure0.0530.102
 Yes78378 (10.0)705 (90.0)1
 No1071138 (12.9)933 (87.1)1.2870.951–1.742
ECOG score0.0270.776
 0–11696189 (11.1)1507 (88.9)1
 2–415827 (17.1)131 (82.9)1.0740.659–1.749
Albumin (g/l)0.0630.360
 >351383148 (10.7)1235 (89.3)1
 30–3536949 (13.3)320 (86.7)0.1651.1870.833–1.6900.343
 25–309016 (17.8)74 (82.2)0.0411.5010.837–2.6930.173
 <25123 (25.0)9 (75.0)0.1281.9760.512–7.6340.323
Surgical duration (min)183.1 (63.9)184.9 (61.0)182.8 (64.2)0.661
All patients (n = 1854)Patients with morbidity (n = 216)Patients without morbidity (n = 1638)P (univariate analysis)OR95% c.i.P (multivariate analysis)
ASA fitness grade<0.001<0.001
 I–II1637170 (10.4)1467 (89.6)1
 III–IV21746 (21.2)171 (78.8)2.1941.470–3.274
Lymph-node dissection0.008
 D287179 (9.1)792 (90.9)1
 D3969136 (14.0)833 (86.0)0.0011.6291.196–2.2180.002
 D1141 (7.1)14 (92.9)0.470.9070.115–7.1550.927
Intraoperative blood loss (ml)0.1090.044
 0–501238131 (10.6)1107 (89.4)1
 50–20056777 (13.6)490 (86.4)0.0651.4401.051–1.9740.023
 >200498 (16.3)41 (83.6)0.2081.7670.790–3.9560.183
Anastomotic type0.0160.160
 End-to-side76469 (9.0)695 (91.0)1
 Side-to-side (extracorporeal)769110 (14.3)659 (87.1)0.0011.451.1.045–2.0140.026
 Side-to-side (intracorporeal)29233 (11.3)259 (88.7)0.2651.2630.804–1.9840.310
 End-to-end294 (13.8)25 (86.2)0.3881.6480.541–5.0240.380
Mesenteric defect closure0.0530.102
 Yes78378 (10.0)705 (90.0)1
 No1071138 (12.9)933 (87.1)1.2870.951–1.742
ECOG score0.0270.776
 0–11696189 (11.1)1507 (88.9)1
 2–415827 (17.1)131 (82.9)1.0740.659–1.749
Albumin (g/l)0.0630.360
 >351383148 (10.7)1235 (89.3)1
 30–3536949 (13.3)320 (86.7)0.1651.1870.833–1.6900.343
 25–309016 (17.8)74 (82.2)0.0411.5010.837–2.6930.173
 <25123 (25.0)9 (75.0)0.1281.9760.512–7.6340.323
Surgical duration (min)183.1 (63.9)184.9 (61.0)182.8 (64.2)0.661

Anastomotic leak

A total of 26 patients (1.4 per cent) had an anastomotic leak within 30 days of surgery (12 Clavien–Dindo II, and 14 Clavien–Dindo III). Twelve patients were treated with antibiotics alone, five with radiologically guided drainage and nine with laparotomy. Through LASSO analysis, three factors were selected as potential predictors of anastomotic leak. At univariate and multivariate analysis, extracorporeal side-to-side anastomosis (P = 0.031), intraoperative blood loss > 50 ml (P = 0.004) and neoadjuvant chemotherapy (P = 0.004) were identified as independent risk factors for anastomotic leak (Table 6, Fig. S3).

Table 6

Predictive factors for anastomotic leak after right hemicolectomy for colon cancer

All patients (n = 1854)Patients with anastomotic leak (n = 26)Patients without anastomotic leak (n = 1828)P (univariate analysis)OR95% c.i.P (multivariate analysis)
Anastomotic type0.0260.031
 End-to-side7643 (0.4)761 (99.6)1
 Side-to-side (extracorporeal)76919 (2.5)750 (97.5)0.0036.4151.879–21.8980.003
 Side-to-side (intracorporeal)2924 (1.4)288 (98.6)0.1014.3320.95–19.7480.058
 End-to-end290 (0.0)29 (100)0.998
Intraoperative blood loss0.0030.004
 0–50123810 (0.8)1228 (99.2)
 50–20056713 (2.3)554 (97.7)0.0122.9771.282–6.9170.011
 >200493 (6.5)46 (93.5)0.0027.3551.900–28.4770.004
Neoadjuvant chemotherapy0.0050.004
 No178422 (1.2)1762 (98.8)1
 Yes704 (5.7)66 (94.3)5.1741.676–15.977
All patients (n = 1854)Patients with anastomotic leak (n = 26)Patients without anastomotic leak (n = 1828)P (univariate analysis)OR95% c.i.P (multivariate analysis)
Anastomotic type0.0260.031
 End-to-side7643 (0.4)761 (99.6)1
 Side-to-side (extracorporeal)76919 (2.5)750 (97.5)0.0036.4151.879–21.8980.003
 Side-to-side (intracorporeal)2924 (1.4)288 (98.6)0.1014.3320.95–19.7480.058
 End-to-end290 (0.0)29 (100)0.998
Intraoperative blood loss0.0030.004
 0–50123810 (0.8)1228 (99.2)
 50–20056713 (2.3)554 (97.7)0.0122.9771.282–6.9170.011
 >200493 (6.5)46 (93.5)0.0027.3551.900–28.4770.004
Neoadjuvant chemotherapy0.0050.004
 No178422 (1.2)1762 (98.8)1
 Yes704 (5.7)66 (94.3)5.1741.676–15.977
Table 6

Predictive factors for anastomotic leak after right hemicolectomy for colon cancer

All patients (n = 1854)Patients with anastomotic leak (n = 26)Patients without anastomotic leak (n = 1828)P (univariate analysis)OR95% c.i.P (multivariate analysis)
Anastomotic type0.0260.031
 End-to-side7643 (0.4)761 (99.6)1
 Side-to-side (extracorporeal)76919 (2.5)750 (97.5)0.0036.4151.879–21.8980.003
 Side-to-side (intracorporeal)2924 (1.4)288 (98.6)0.1014.3320.95–19.7480.058
 End-to-end290 (0.0)29 (100)0.998
Intraoperative blood loss0.0030.004
 0–50123810 (0.8)1228 (99.2)
 50–20056713 (2.3)554 (97.7)0.0122.9771.282–6.9170.011
 >200493 (6.5)46 (93.5)0.0027.3551.900–28.4770.004
Neoadjuvant chemotherapy0.0050.004
 No178422 (1.2)1762 (98.8)1
 Yes704 (5.7)66 (94.3)5.1741.676–15.977
All patients (n = 1854)Patients with anastomotic leak (n = 26)Patients without anastomotic leak (n = 1828)P (univariate analysis)OR95% c.i.P (multivariate analysis)
Anastomotic type0.0260.031
 End-to-side7643 (0.4)761 (99.6)1
 Side-to-side (extracorporeal)76919 (2.5)750 (97.5)0.0036.4151.879–21.8980.003
 Side-to-side (intracorporeal)2924 (1.4)288 (98.6)0.1014.3320.95–19.7480.058
 End-to-end290 (0.0)29 (100)0.998
Intraoperative blood loss0.0030.004
 0–50123810 (0.8)1228 (99.2)
 50–20056713 (2.3)554 (97.7)0.0122.9771.282–6.9170.011
 >200493 (6.5)46 (93.5)0.0027.3551.900–28.4770.004
Neoadjuvant chemotherapy0.0050.004
 No178422 (1.2)1762 (98.8)1
 Yes704 (5.7)66 (94.3)5.1741.676–15.977

Discussion

Our study prospectively enrolled patients with right colon cancer who underwent RHC in 52 tertiary hospitals, providing valuable insights into the current clinical practice of RHC in high-volume expert centres in China. Additionally, this study reported low rates of conversion, morbidity, and mortality10,11,22,23, which differs significantly from previous studies24,25. This difference can be attributed to the screening of enrolment centres and patients, which helped to identify and implement effective clinical practices. The patients included in our study in China were relatively younger than those in previous European Society of Coloproctology Collaborating Group (ESCP) studies10, with 88.3 per cent of patients being ASA I–II and exclusion of emergency surgery, indicating better baseline conditions. The lower BMI most probably also made the operations easier to perform. Furthermore, over 95 per cent of operations were performed by chief or associate chief surgeons with extensive experience in laparoscopic surgery, contributing to the excellent clinical outcomes reported in this study. The length of postoperative hospital stay was 8 (6–10) days, which is consistent with the findings of the REAL study conducted in China26. Although this might be related to cultural factors, it also indicates that enhanced recovery after surgery (ERAS) protocols are not being implemented effectively in most Chinese centres.

This study also found that laparoscopic surgery has been widely implemented in high-volume expert centres, with D3 lymph node dissection rates exceeding 50 per cent. However, the surgical time was longer than that reported in the ESCP study, possibly due to the complexity of the surgery. Comparing anastomotic techniques to the ESCP study, stapled anastomosis (97.8 per cent versus 59.8 per cent) and end-to-side anastomosis (41.2 per cent versus 11.3 per cent) were significantly higher, while intracorporeal anastomosis was comparable (15.7 per cent versus 17.4 per cent)10.

Anastomotic leak is a major complication after RHC and has a negative impact on short- and long-term outcomes10–14. The incidence of anastomotic leak varies widely from 1.0 per cent to 8.4 per cent6,10,11,27,28. Anastomotic leak rates in retrospective studies ranged from 4 to 8 per cent10,11,22, and 1–3 per cent in RCTs6,27,28. Our study reported an anastomotic leak rate of only 1.4 per cent. In addition to excluding high-risk emergency surgery and inflammatory bowel disease, and selecting high-volume expert centres, the definition and diagnosis of anastomotic leak may impact upon this reported rate. There is currently no uniform definition of anastomotic leak after RHC. The ESCP defines both clinically suspected anastomotic leaks confirmed radiologically or intraoperatively (type 1) and the presence of an intraperitoneal fluid collection (type 2), reporting 4.6 per cent (type 1 only) and 7.4 per cent (types 1 and 2 combined)10. This revealed that a broad definition may contribute to high reporting of anastomotic leak. Because regular postoperative imaging was not necessary, this study required clinical suspicion of anastomotic leak to then undertake radiological examination.

In the present analysis, extracorporeal side-to-side anastomosis, intraoperative bleeding > 50 ml and neoadjuvant chemotherapy were identified as independent risk factors for anastomotic leak after RHC. Compared with end-to-side anastomosis, side-to-side anastomosis is wider, and cross-stapling in an isoperistaltic fashion (more commonly used in extracorporeal anastomoses) may increase the risk of anastomotic leak. Previous studies have shown that the leak rate of a stapled end-to-side anastomosis was similar to that of a hand-sewn anastomosis, but much higher for stapled side-to-side anastomoses29. A study from ESCP also revealed that the anastomotic leak rate was higher in stapled anastomosis, in which side-to-side anastomosis accounted for 87.8 per cent10. Interestingly, side-to-side anastomosis was performed in all intracorporeal anastomoses, and although no significant difference in leak rate was shown compared with extracorporeal anastomosis (0.4 per cent versus 1.4 per cent, P = 0.058), this may be due to the fact that an isoperistaltic anastomosis, which had no cross-stapling, was more commonly used in the intracorporeal setting. In addition, reduced mobilization and torsion of the mesentery may improve the blood supply of the anastomosis, although further studies are required to investigate this. Considering that intracorporeal anastomosis was used infrequently, there is a learning curve that needs to be overcome.

Intraoperative bleeding was another risk factor for anastomotic leak, which was consistent with previous studies30,31. Intraoperative bleeding was considered a sign of surgical damage and may slow wound healing. Neoadjuvant chemotherapy was also identified as an independent risk factor for anastomotic leak in our study, but this conclusion is not consistently reported32–34. Nevertheless, attention must be given to the optimal timing for surgery and perioperative management in patients receiving neoadjuvant chemotherapy. Our study found no significant negative impact of ASA classification, malnutrition, open surgery, or duration of surgery on anastomotic leak.

ASA category and intraoperative bleeding are well known to be predictors of postoperative morbidity35,36. In this study, D3 lymph node dissection was an independent risk factor for morbidity, although it has not been consistently reported as such2,4,37. The recent RELARC study reported a similar complication rate in CME compared with D2 lymph node dissection but increased risk of vascular injury6. The number of harvested lymph nodes were significantly higher in the CME group, and 3 per cent of central lymph nodes were detected to be metastatic. Data on whether these pathological benefits will improve prognosis is highly anticipated. Although D3 lymph node dissection has been performed in many centres, attention consideration must be given to the potential for increased morbidity, and appropriate patient selection and perioperative management are necessary.

The main strength of this study is that the data from a large sample of high-volume expert centres in China were prospectively collected. This ensures the homogeneity of data as much as possible by excluding patient and surgeon factors, and more accurately predicting those factors related to surgical technique and postoperative outcomes. The limitations of this study are as follows: this is an observational study, and selection bias needs to be considered; the generalizability of the study findings may be affected as we have screened both surgical centres and patients; there is currently no uniform definition for anastomotic leak, only clinically diagnosed anastomotic leak is identified here, and some radiological anastomotic leaks may have been undetected; due to the limited collection of variables, complications other than those related to surgery, such as respiratory or cardiac complications, were not collected in sufficient detail; due to the low incidence of target events, there may be a risk of bias during statistical analysis. However, the LASSO methodology is capable of producing a model that only includes a subset of the predictor variables to reduce the bias from other confounding factors.

Conclusion

In high-volume expert centres in China, laparoscopic RHC and D3 lymph node dissection were performed in most patients, and overall postoperative morbidity and mortality were low. An ASA fitness grade > II, intraoperative blood loss > 50 ml and D3 lymph node dissection were identified as independent risk factors for morbidity. Extracorporeal side-to-side anastomosis, intraoperative blood loss > 50 ml and neoadjuvant chemotherapy were identified as independent risk factors for anastomotic leak. Further high-quality studies should focus on the optimal techniques for radical tumour resection and anastomosis, for which the results of this study will provide a basis.

Collaborators

Jurriaan Tuynman, Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands

Email: [email protected]

Hendrik Bonjer, Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands

Email: [email protected]

Hongwei Yao, Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center of Digestive Diseases, Beijing 100050, China

Email: [email protected]

Zhongtao Zhang, Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center of Digestive Diseases, Beijing 100050, China

Email: [email protected]

Funding

This work was supported by grants from the National Key Technologies R&D Program (No. 2015BAI13B09), National Key Technologies R&D Program of China (No. 2017YFC0110904), Clinical Center for Colorectal Cancer, Capital Medical University (No. 1192070313).

Acknowledgements

The authors acknowledge the all the RHC-SNAPSHOT investigators (Appendix 2). The authors also thank Yuanyuan Kong (Department of Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital) for guidance on methodology, and Yishan Liu (National Clinical Research Center of Digestive Diseases) for her data monitoring assistance.

Disclosure

No potential conflict of interest was reported by the authors.

Supplementary material

Supplementary material is available at BJS online.

Data availability

Data used and analysed during this study are available from the corresponding author on reasonable request.

References

1

Zheng
R
,
Zhang
S
,
Zeng
H
,
Wang
S
,
Sun
K
,
Chen
R
et al.
Cancer incidence and mortality in China, 2016
.
J Natl Cancer Center
2022
;
2
:
1
9

2

Crane
J
,
Hamed
M
,
Borucki
JP
,
El-Hadi
A
,
Shaikh
I
,
Stearns
AT
.
Complete mesocolic excision versus conventional surgery for colon cancer: a systematic review and meta-analysis
.
Colorectal Dis
2021
;
23
:
1670
1686

3

Di Buono
G
,
Buscemi
S
,
Cocorullo
G
,
Sorce
V
,
Amato
G
,
Bonventre
G
et al.
Feasibility and safety of laparoscopic complete mesocolic excision (CME) for right-sided colon cancer: short-term outcomes. A randomized clinical study
.
Ann Surg
2021
;
274
:
57
62

4

Díaz-Vico
T
,
Fernández-Hevia
M
,
Suárez-Sánchez
A
,
García-Gutiérrez
C
,
Mihic-Góngora
L
,
Fernández-Martínez
D
et al.
Complete mesocolic excision and D3 lymphadenectomy versus conventional colectomy for colon cancer: a systematic review and meta-analysis
.
Ann Surg Oncol
2021
;
28
:
8823
8837

5

Karachun
A
,
Panaiotti
L
,
Chernikovskiy
I
,
Achkasov
S
,
Gevorkyan
Y
,
Savanovich
N
et al.
Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial)
.
Br J Surg
2020
;
107
:
499
508

6

Xu
L
,
Su
X
,
He
Z
,
Zhang
C
,
Lu
J
,
Zhang
G
et al.
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
.
Lancet Oncol
2021
;
22
:
391
401

7

Allaix
ME
,
Degiuli
M
,
Bonino
MA
,
Arezzo
A
,
Mistrangelo
M
,
Passera
R
et al.
Intracorporeal or extracorporeal ileocolic anastomosis after laparoscopic right colectomy: a double-blinded randomized controlled trial
.
Ann Surg
2019
;
270
:
762
767

8

Bollo
J
,
Turrado
V
,
Rabal
A
,
Carrillo
E
,
Gich
I
,
Martinez
MC
et al.
Randomized clinical trial of intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy (IEA trial)
.
Br J Surg
2020
;
107
:
364
372

9

van Oostendorp
S
,
Elfrink
A
,
Borstlap
W
,
Schoonmade
L
,
Sietses
C
,
Meijerink
J
et al.
Intracorporeal versus extracorporeal anastomosis in right hemicolectomy: a systematic review and meta-analysis
.
Surg Endosc
2017
;
31
:
64
77

10

2015 European Society of Coloproctology Collaborating Group
.
Predictors for anastomotic leak, postoperative complications, and mortality after right colectomy for cancer: results from an international snapshot audit
.
Dis Colon Rectum
2020
;
63
:
606
618

11

Frasson
M
,
Granero-Castro
P
,
Ramos Rodríguez
JL
,
Flor-Lorente
B
,
Braithwaite
M
,
Martí Martínez
E
et al.
Risk factors for anastomotic leak and postoperative morbidity and mortality after elective right colectomy for cancer: results from a prospective, multicentric study of 1102 patients
.
Int J Colorectal Dis
2016
;
31
:
105
114

12

Koedam
TWA
,
Bootsma
BT
,
Deijen
CL
,
van de Brug
T
,
Kazemier
G
,
Cuesta
MA
et al.
Oncological outcomes after anastomotic leakage after surgery for colon or rectal cancer: increased risk of local recurrence
.
Ann Surg
2022
;
275
:
e420
e427

13

Zimmermann
MS
,
Wellner
U
,
Laubert
T
,
Ellebrecht
DB
,
Bruch
HP
,
Keck
T
et al.
Influence of anastomotic leak after elective colorectal cancer resection on survival and local recurrence: a propensity score analysis
.
Dis Colon Rectum
2019
;
62
:
286
293

14

Branagan
G
,
Finnis
D
.
Prognosis after anastomotic leakage in colorectal surgery
.
Dis Colon Rectum
2005
;
48
:
1021
1026

15

van Helsdingen
CP
,
Jongen
AC
,
de Jonge
WJ
,
Bouvy
ND
,
Derikx
JPM
.
Consensus on the definition of colorectal anastomotic leakage: a modified Delphi study
.
World J Gastroenterol
2020
;
26
:
3293
3303

16

Rahbari
NN
,
Weitz
J
,
Hohenberger
W
,
Heald
RJ
,
Moran
B
,
Ulrich
A
et al.
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer
.
Surgery
2010
;
147
:
339
351

17

Dindo
D
,
Demartines
N
,
Clavien
PA
.
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey
.
Ann Surg
2004
;
240
:
205
213

18

Kulu
Y
,
Ulrich
A
,
Bruckner
T
,
Contin
P
,
Welsch
T
,
Rahbari
NN
et al.
Validation of the International Study Group of Rectal Cancer definition and severity grading of anastomotic leakage
.
Surgery
2013
;
153
:
753
761

19

Gamo
E
,
Jiménez
C
,
Pallares
E
,
Simón
C
,
Valderrama
F
,
Sañudo
JR
et al.
The superior mesenteric artery and the variations of the colic patterns. A new anatomical and radiological classification of the colic arteries
.
Surg Radiol Anat
2016
;
38
:
519
527

20

He
Z
,
Su
H
,
Ye
K
,
Sun
Y
,
Guo
Y
,
Wang
Q
et al.
Anatomical characteristics and classifications of gastrocolic trunk of Henle in laparoscopic right colectomy: preliminary results of multicenter observational study
.
Surg Endosc
2020
;
34
:
4655
4661

21

Tibshirani
R
.
Regression shrinkage and selection via the LASSO
.
J R Stat Soc Series B (Methodological)
1996
;
58
:
267
288

22

Bakker
IS
,
Grossmann
I
,
Henneman
D
,
Havenga
K
,
Wiggers
T
.
Risk factors for anastomotic leakage and leak-related mortality after colonic cancer surgery in a nationwide audit
.
Br J Surg
2014
;
101
:
424
432
; discussion 432

23

Sparreboom
CL
,
van Groningen
JT
,
Lingsma
HF
,
Wouters
M
,
Menon
AG
,
Kleinrensink
GJ
et al.
Different risk factors for early and late colorectal anastomotic leakage in a nationwide audit
.
Dis Colon Rectum
2018
;
61
:
1258
1266

24

Borowski
DW
,
Bradburn
DM
,
Mills
SJ
,
Bharathan
B
,
Wilson
RG
,
Ratcliffe
AA
et al.
Volume-outcome analysis of colorectal cancer-related outcomes
.
Br J Surg
2010
;
97
:
1416
1430

25

Archampong
D
,
Borowski
D
,
Wille-Jørgensen
P
,
Iversen
LH
.
Workload and surgeon’s specialty for outcome after colorectal cancer surgery
.
Cochrane Database Syst Rev
2012
;
3
:
Cd005391

26

Feng
Q
,
Yuan
W
,
Li
T
,
Tang
B
,
Jia
B
,
Zhou
Y
et al.
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial
.
Lancet Gastroenterol Hepatol
2022
;
7
:
991
1004

27

Veldkamp
R
,
Kuhry
E
,
Hop
WC
,
Jeekel
J
,
Kazemier
G
,
Bonjer
HJ
et al.
Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial
.
Lancet Oncol
2005
;
6
:
477
484

28

Yamamoto
S
,
Inomata
M
,
Katayama
H
,
Mizusawa
J
,
Etoh
T
,
Konishi
F
et al.
Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404
.
Ann Surg
2014
;
260
:
23
30

29

Rajan
R
,
Arachchi
A
,
Metlapalli
M
,
Lo
J
,
Ratinam
R
,
Nguyen
TC
et al.
Ileocolic anastomosis after right hemicolectomy: stapled end-to-side, stapled side-to-side, or handsewn?
Int J Colorectal Dis
2022
;
37
:
673
681

30

Kawada
K
,
Hasegawa
S
,
Hida
K
,
Hirai
K
,
Okoshi
K
,
Nomura
A
et al.
Risk factors for anastomotic leakage after laparoscopic low anterior resection with DST anastomosis
.
Surg Endosc
2014
;
28
:
2988
2995

31

Contant
CM
,
Hop
WC
,
van’t Sant
HP
,
Oostvogel
HJ
,
Smeets
HJ
,
Stassen
LP
et al.
Mechanical bowel preparation for elective colorectal surgery: a multicentre randomised trial
.
Lancet
2007
;
370
:
2112
2117

32

Midura
EF
,
Hanseman
D
,
Davis
BR
,
Atkinson
SJ
,
Abbott
DE
,
Shah
SA
et al.
Risk factors and consequences of anastomotic leak after colectomy: a national analysis
.
Dis Colon Rectum
2015
;
58
:
333
338

33

Trencheva
K
,
Morrissey
KP
,
Wells
M
,
Mancuso
CA
,
Lee
SW
,
Sonoda
T
et al.
Identifying important predictors for anastomotic leak after colon and rectal resection: prospective study on 616 patients
.
Ann Surg
2013
;
257
:
108
113

34

Arredondo
J
,
Pastor
E
,
Simó
V
,
Beltrán
M
,
Castañón
C
,
Magdaleno
MC
et al.
Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review
.
Tech Coloproctol
2020
;
24
:
1001
1015

35

Hackett
NJ
,
De Oliveira
GS
,
Jain
UK
,
Kim
JY
.
ASA class is a reliable independent predictor of medical complications and mortality following surgery
.
Int J Surg
2015
;
18
:
184
190

36

Parthasarathy
M
,
Greensmith
M
,
Bowers
D
,
Groot-Wassink
T
.
Risk factors for anastomotic leakage after colorectal resection: a retrospective analysis of 17 518 patients
.
Colorectal Dis
2017
;
19
:
288
298

37

Mazzarella
G
,
Muttillo
EM
,
Picardi
B
,
Rossi
S
,
Muttillo
IA
.
Complete mesocolic excision and D3 lymphadenectomy with central vascular ligation in right-sided colon cancer: a systematic review of postoperative outcomes, tumor recurrence and overall survival
.
Surg Endosc
2021
;
35
:
4945
4955

Author notes

Jiale Gao, Xiaodong Gu, Minghui Pang, Hong Zhang, Yugui Lian, Lei Zhou, Bo Feng, Guiying Wang, Zhicao Zhang, He Huang, Gang Xiao, Fanghai Han, Xinxiang Li shared first authorship and contributed equally to this work.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]

Supplementary data